Affordable Medicines Threatened as Patents Restrict Access Globally
The article examines how patents on new medicines affect their availability and cost after the TRIPS agreement. TRIPS requires most countries to grant 20-year patents on pharmaceutical products, except for the least-developed countries. By 2005, developing countries were supposed to follow this rule.